製品: Galectin 1 Antibody
カタログ: DF2383
タンパク質の説明: Rabbit polyclonal antibody to Galectin 1
アプリケーション: WB IHC IF/ICC
Cited expt.: IHC, IF/ICC
反応性: Human, Mouse, Rat
予測: Bovine, Horse, Sheep, Dog
分子量: 14kDa; 15kD(Calculated).
ユニプロット: P09382
RRID: AB_2839591

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:500-1:2000, IF/ICC 1:100-1:500, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
予測:
Bovine(100%), Horse(86%), Sheep(100%), Dog(86%)
クローナリティ:
Polyclonal
特異性:
Galectin 1 Antibody detects endogenous levels of total Galectin 1.
RRID:
AB_2839591
引用形式: Affinity Biosciences Cat# DF2383, RRID:AB_2839591.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

14 kDa laminin-binding protein; 14 kDa lectin; Beta galactoside binding lectin; Beta galactoside binding lectin L 14 I; beta galactoside binding protein; Beta-galactoside-binding lectin L-14-I; DKFZp686E23103; Gal 1; Gal-1; GAL1; Galaptin; Galbp; Galectin; Galectin-1; Galectin1; GBP; HBL; HLBP14; HPL; L 14.5; L-14.5; L14; Lactose binding lectin 1; Lactose-binding lectin 1; Lect14; Lectin galactoside binding soluble 1; Lectin galactoside-binding soluble 1; LEG1_HUMAN; LGALS 1; LGALS1; Lgals1 lectin galactose binding soluble 1; MAPK activating protein MP12; Putative MAPK activating protein MP12; Putative MAPK-activating protein PM12; S Lac lectin 1; S-Lac lectin 1;

免疫原

免疫原:

A synthesized peptide derived from human Galectin 1, corresponding to a region within the internal amino acids.

Uniprot:
遺伝子(ID):
発現特異性:
P09382 LEG1_HUMAN:

Expressed in placenta, maternal decidua and fetal membranes. Within placenta, expressed in trophoblasts, stromal cells, villous endothelium, syncytiotrophoblast apical membrane and villous stroma. Within fetal membranes, expressed in amnion, chorioamniotic mesenchyma and chorion (at protein level). Expressed in cardiac, smooth, and skeletal muscle, neurons, thymus, kidney and hematopoietic cells.

タンパク質配列:
MACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD

種類予測

種類予測:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Bovine
100
Sheep
100
Horse
86
Dog
86
Rabbit
71
Pig
0
Xenopus
0
Zebrafish
0
Chicken
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

研究背景

機能:

Lectin that binds beta-galactoside and a wide array of complex carbohydrates. Plays a role in regulating apoptosis, cell proliferation and cell differentiation. Inhibits CD45 protein phosphatase activity and therefore the dephosphorylation of Lyn kinase. Strong inducer of T-cell apoptosis.

細胞の位置付け:

Secreted>Extracellular space>Extracellular matrix.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
組織特異性:

Expressed in placenta, maternal decidua and fetal membranes. Within placenta, expressed in trophoblasts, stromal cells, villous endothelium, syncytiotrophoblast apical membrane and villous stroma. Within fetal membranes, expressed in amnion, chorioamniotic mesenchyma and chorion (at protein level). Expressed in cardiac, smooth, and skeletal muscle, neurons, thymus, kidney and hematopoietic cells.

参考文献

1). Dihydroartemisinin inhibits galectin-1-induced ferroptosis resistance and peritoneal metastasis of gastric cancer via the Nrf2-HO-1 pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2025 (PubMed: 41166905) [IF=6.7]

Application: IHC    Species: human    Sample: GC tissues

Fig. 1. Galectin-1 plays a critical role in GCPM. (A) Representative images of H&E staining and galectin-1 IHC in GC tissues from patients with or without PM. (B) IRS scores of galectin-1 expression in GC tissues from patients with or without PM(n = 132). (C) Data from the GEPIA database showing the expression levels of LGALS1 in GC tissues compared with normal tissues. (D) The TIMER database illustrates LGALS1 expression in tumour and adjacent normal tissues. GEPIA data further indicate that LGALS1 expression correlates with the detailed clinical stage (E) and gross tumour stage (F) of GC. The Kaplan–Meier survival analysis demonstrates the associations between LGALS1 expression and the first-progression survival (G), postprogression survival (H), and overall survival (I) of GC patients. (J) A representative image showing the GCPM model using HGC-27 cells with different levels of galectin-1 expression. (K) Statistical analysis of the number of peritoneal metastatic nodules across the experimental groups. (L) H&E staining confirmed that the peritoneal nodules were adenocarcinoma tissue(400 × magnification). WT: Wild Type; NS: not statistically significant

Application: IF/ICC    Species: human    Sample: HGC-27 cells

Fig. 2. Galectin-1 increases the proliferation, invasion, and migration of GC cells. Representative images of PI/calcein staining in HGC-27 (A) and SGC-7901 (B) cell lines with varying levels of galectin-1 expression(200 × magnification). (C) Quantitative analysis of live cell proportions in all experimental groups by PI/calcein-AM staining. Representative images of EdU-stained HGC-27 (D) and SGC-7901 (E) cells with different galectin-1 expression levels(200 × magnification). (F) Quantification of EdU-positive cells in the various groups.(G)Representative images illustrating the migratory and invasive capacities of GC cells with altered galectin-1 expression(200 × magnification). (H) Statistical analyses of the number of migrated and invaded cells, respectively. (I)Representative images from colony formation assays performed in HGC-27 and SGC-7901 cells. (J) Quantitative results of colony-forming units for HGC-27 and SGC-7901 cells, respectively. WT: Wild Type; NS: not statistically significant

2). Establishment of papillary thyroid cancer organoid lines from clinical specimens. Frontiers in Endocrinology, 2023 (PubMed: 36992805) [IF=3.9]

Application: IF/ICC    Species: Mouse    Sample:

Figure 4 Immunofluorescence staining of CK19, Gal-1, Gal-3, and Ki-67 on PTC- and NTG-derived organoids and the matched tumor tissues. Nuclei were counterstained with DAPI (blue). Passage numbers of these organoid lines were: PTC-3_O, P3; PTC-10_O, P5; NTG-1_O, P4. CK19, Cytokeratin 19; Gal-1, Galectin-1; Gal-3, Galectin-3; NTG, nodular thyroid goiter; T, tumor; O, organoid. Scale bar, 100 µm.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.